Basic Materials / Specialty ChemicalsNSE
$421.20
+3.30 (+0.79%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 34% · confianza 17%
FCF escenarios
weak_data · normalized FCF $-67.1M · quality 39.7/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
49/100
C
Piotroski
5/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$4.3B
P/E
23.1x
↑EV/EBITDA
N/A
•ROE
10.4%
↑Gross Margin
21.1%
↑Debt/Equity
0.36
↑TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2023–2026 · 3 años de histórico normalizado
Revenue CAGR
+34.4%
FCF CAGR
—
FCF margin
-2.1%
FCF / Net income
-0.36x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $3.15B · net income $187.7M · FCF $-67.1M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2026 | 2025 | 2024 | 2023 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $3.15B | $3.15B | $2.88B | $2.70B | $1.30B |
| Net Income | $187.7M | $187.7M | $144.7M | $222.0M | $143.4M |
| EBITDA | $-57.1M | $-57.1M | $25.8M | $445.1M | $242.2M |
| EPS | 18.26 | 18.26 | 14.03 | 22.76 | 15.24 |
| Gross Margin | 21.1% | 21.1% | 20.0% | 21.7% | 24.9% |
| Operating Margin | 11.2% | 11.2% | 9.5% | 13.6% | 17.5% |
| Net Margin | 6.0% | 6.0% | 5.0% | 8.2% | 11.1% |
| Balance Sheet | |||||
| Debt/Equity | 0.36 | 0.36 | 0.48 | 0.47 | 0.44 |
| Current Ratio | 3.22 | 3.22 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $-67.1M | $-67.1M | $165.3M | $-690.9M | $-221.1M |
| Returns | |||||
| ROE | 10.4% | 10.4% | 10.1% | 15.4% | 18.7% |
| Valuation | |||||
| P/E | 23.07 | 23.07 | 26.91 | 52.23 | 28.65 |
| EV/EBITDA | — | — | 177.16 | 27.47 | 18.36 |
| P/B | 2.40 | 2.40 | 2.72 | 8.05 | 5.36 |
| Growth & Yield | |||||
| Revenue Growth | 9.3% | 9.3% | 6.5% | 108.5% | — |
| EPS Growth | 30.1% | 30.1% | -38.4% | 49.3% | — |
| Dividend Yield | 0.2% | 0.2% | — | — | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
27.0%
EPS terminal req.
$37.37
Spread vs growth
3.2%
5Y implied EPS CAGR
19.9%
EPS terminal req.
$45.22
Spread vs growth
10.3%
10Y implied EPS CAGR
14.8%
EPS terminal req.
$72.83
Spread vs growth
15.3%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
+4.4%
Start / end P/E
28.8x → 23.1x
EPS bridge
14.03 → 18.26
Residual
-6.0%
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.